學 習 工 作 經(jīng) 歷 |
學習經(jīng)歷: 2009.09至2013.07山西醫(yī)科大學, 勞動衛(wèi)生與環(huán)境衛(wèi)生, 博士 2006.09至2009.07, 山西醫(yī)科大學, 藥物化學, 碩士, 2002.09至2006.07, 山西醫(yī)科大學, 藥學, 學士 工作經(jīng)歷: 2019.01至今 山西醫(yī)科大學, 藥學院, 副教授 2013.11至2018.12, 山西醫(yī)科大學, 藥學院, 講師 |
代表性論文 |
1.Li Tang#, Jie-ran Luo#, Dai-tian Li#, RuiGe, Yun-long Ma, FeiXu, Tai-gang Liang, Shu-rong Ban, Qing-shan Li*. Anti-inflammatory effects of 4-o-methyl-benzenesulfonyl benzoxazolone (MBB) in vivo and in vitro as a novel NSAIDs lead compound. Pharmacological Reports, 2018, 70(3): 558-564. 2.Li Tang#,Jie-ran Luo#, Yun-lan Li, RuiGe, Qing-Shan Li*. Hepatotoxicity and proteomic mechanism of Di-n-butyl-di-(4-chlorobenzohydroxamato)tin(IV) (DBDCT) in vivo. Environmental Toxicology and Pharmacology. 2017, 51: 38–44. 3.Li Tang#, Wen-Hua Ma#, Yun-Long Ma, Shu-Rong Ban, Xiu-E Feng, Qing-Shan Li*. Synthesis and biological activity of 4-substituted benzoxazolone derivatives as a new class of sEH inhibitors with high anti-inflammatory activity in vivo. Bioorganic & Medicinal Chemistry Letters. 2013, 23: 2380-2383. 4.Li Tang#, Yun-lan Li#, RuiGe, Qing-Shan Li*. Oxidative stress in di-n-butyl-di-(4-chlorobenzohydroxamato)tin (IV)-induced hepatotoxicity determined by proteomic profiles. Toxicology Letters. 2012, 213: 167-173. 5.Xiao-xia Liu#, Li Tang#,RuiGe, Jian-kuan Li, Ya Kang, Mei-xia Zhu, Qing Shan Li*, Xu-liangHao*. iTRAQ-based quantitative proteomic analysis of the anti-apoptotic effect of hyperin, which is mediated by Mcl-1 and Bid, in H2O2-injured EA.hy926 cells. International Journal of Molecular Medicine. 2016, 37:1083-1090 |